SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Oct 9, 2017

2. SEC Identification Number

A200016575

3. BIR Tax Identification No.

005-695-791

4. Exact name of issuer as specified in its charter

PHILAB HOLDINGS CORP. (formerly Alterra Capital Partners, Inc.)

5. Province, country or other jurisdiction of incorporation

Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

8th Floor, 1128 38th Avenue, Fort Bonifacio Global City, Taguig City, Metro Manila Postal Code 1634

8. Issuer's telephone number, including area code

(02)5519639

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	62,276,060

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Philab Holdings Corp.DNA

PSE Disclosure Form 4-8 - Change in Directors and/or Officers
(Resignation/Removal or Appointment/Election)
References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Resignation and Change in Position of Directors and Officers
Background/Description of the Disclosure
On 9 October 2017, Mr. Ramon B. Cardenas and Mr. Hector Thomas A. Navasero were elected as an Independent Director and Director of the Company respectively. Ms. Darlene Marie B. Berberabe resigned as director and as Chief Executive Officer and President of the Company.

Resignation/Removal or Replacement

Name of Person	Position/Designation	Effective Date of Resignation/Cessation of term (mmm/dd/yyyy)	Reason(s) for Resignation/Cessation
Darlene Marie B. Berberabe	CEO/President	10-09-2017	Please see attached.
Darlene Marie B. Berberabe	Director	10-09-2017	Please see attached.

Election or Appointment

Name of Person	Position/Designation	Date of Appointment/Election (mmm/dd/yyyy)	Effective Date of Appointment Election (mmm/dd/yyyy)	Shareholdings in the Listed Company		Nature of Indirect Ownership
				Direct	Indirect
Ramon B. Cardena	Director	10-09-2017	10-09-2017	200	-	-
Hector Thomas A. Navasero	Director	10-09-2017	10-09-2017	1,719,947,612	686,248	Through Genomics, Inc.

Promotion or Change in Designation

Name of Person	Position/Designation		Date of Approval (mmm/dd/yyyy)	Effective Date of Change (mmm/dd/yyyy)	Shareholdings in the Listed Company		Nature of Indirect Ownership
	From	To			Direct	Indirect
-	-	-	-	-	-	-	-

Other Relevant Information
Please see attached for the reason of resignation of Ms. Darlene Marie B. Berberabe as Director and President/CEO of the Company.